Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3532
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnthony, E.en
dc.contributor.authorZappala, T.en
dc.contributor.authorKar, R.en
dc.date.accessioned2022-11-07T23:43:24Z-
dc.date.available2022-11-07T23:43:24Z-
dc.date.issued2016en
dc.identifier.citation57 , 2016, p. 38en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/3532-
dc.description.abstractLinear immunoglobulin A (IgA) bullous dermatosis (LABD) is a rare autoimmune mucocutaneous disorder characterized by subepithelial bullae, with IgA autoantibodies directed against several different antigens in the basement membrane zone. Its immunopathologic characteristic resides in the presence of a continuous linear IgA deposit along the basement membrane zone, which is clearly visible on direct immunofluorescence. It occurs in both adults and children, although the childhood form is most frequently termed “chronic bullous disease of childhood”. The clinical picture can be varied, and diagnosis is achieved via clinical, histopathological and immunopathologic examinations. Two illustrative cases are described. A 71 year old female with vancomycin induced LABD, and a 4 year old girl with chronic bullous disease of childhood. The differential diagnoses, histopathology and management options will be discussed. An assessment of a triggering drug should always be suspected and ceased appropriately. Two common therapies are dapsone and sulfapyridine, which reduce the inflammatory response and achieve disease remission in a variable period of time. In certain cases oral prednisone may need to be added to achieve control of the disease. Successful treatment of adult and childhood LABD with antibiotics, including dicloxacillin, erythromycin, tetracycline, and trimethoprim-sulfamethoxazole has also been reported.L723041262016-06-29 <br />en
dc.language.isoenen
dc.relation.ispartofAustralasian Journal of Dermatologyen
dc.titleLinear IgA bullous dermatosisen
dc.typeArticleen
dc.identifier.doi10.1111/ajd.12480en
dc.subject.keywordschildhooden
dc.subject.keywordsbasement membraneen
dc.subject.keywordsadulten
dc.subject.keywordsfemaleen
dc.subject.keywordsgirlen
dc.subject.keywordsbullous skin diseaseen
dc.subject.keywordsdifferential diagnosisen
dc.subject.keywordsdiagnosisen
dc.subject.keywordsexaminationen
dc.subject.keywordshistopathologyen
dc.subject.keywordsremissionen
dc.subject.keywordschilden
dc.subject.keywordsinflammationen
dc.subject.keywordsimmunofluorescenceen
dc.subject.keywordstherapyen
dc.subject.keywordsdiseasesen
dc.subject.keywordsblisteren
dc.subject.keywordsimmunoglobulin Aantigenen
dc.subject.keywordsprednisoneen
dc.subject.keywordsautoantibodyen
dc.subject.keywordsantibiotic agenten
dc.subject.keywordstetracyclineen
dc.subject.keywordsvancomycinen
dc.subject.keywordssulfapyridineen
dc.subject.keywordsdapsoneen
dc.subject.keywordsdicloxacillinen
dc.subject.keywordserythromycinen
dc.subject.keywordscotrimoxazoleen
dc.subject.keywordslinear iga bullous dermatosisen
dc.subject.keywordscollegeen
dc.subject.keywordsdermatologisten
dc.subject.keywordshumanen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L72304126&from=exporthttp://dx.doi.org/10.1111/ajd.12480 |en
dc.identifier.risid586en
dc.description.pages38en
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeArticle-
item.languageiso639-1en-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

18
checked on Apr 17, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.